Octave Bioscience Stock

www.octavebio.com/Healthcare / Healthcare softwareFounded: 2014

Octave Bioscience is a biotechnology healthcare platform that enables the care of multiple sclerosis. The company’s intelligence platform tracks disease progression, activity, and MS care experiences. Octave Bioscience was founded by Melinda Thomas and William Hagstrom in 2014 and is headquartered in San Francisco, CA.

Register To Buy and Sell Shares

For more details on financing and valuation for Octave Bioscience, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Octave Bioscience’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Octave Bioscience.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Frequently Asked Questions About Octave Bioscience’s Stock

plusminus
Can you buy Octave Bioscience’s stock?
Octave Bioscience is not publicly traded on NYSE or NASDAQ in the U.S. To buy Octave Bioscience’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Octave Bioscience’s stock?
Yes, you can sell stock of a private company like Octave Bioscience. Forge can help you sell your Octave Bioscience stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Octave Bioscience’s stock price?
Octave Bioscience is a privately held company and therefore does not have a public stock price. However, you may access Octave Bioscience’s private market stock price with Forge Data.
plusminus
What is Octave Bioscience’s stock ticker symbol?
Octave Bioscience does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Octave® Bioscience, Inc. Receives $10 Million Grant from The Michael J. Fox Foundation to Develop and Validate Multi-Analyte Protein Biomarker Test for Parkinson’s Disease Assessments
The neuroscience technology company Octave received a $10 million grant for their treatment of Parkinson's Disease as they create custom protein biomarkers.
Updated on: Apr 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.